These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10399108)

  • 1. A novel exonic mutation in the aspartylglucosaminidase gene causes exon skipping.
    Coulter-Mackie MB
    J Inherit Metab Dis; 1999 Jun; 22(5):682-3. PubMed ID: 10399108
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.
    Isoniemi A; Hietala M; Aula P; Jalanko A; Peltonen L
    Hum Mutat; 1995; 5(4):318-26. PubMed ID: 7627186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
    Saarela J; von Schantz C; Peltonen L; Jalanko A
    Hum Mutat; 2004 Oct; 24(4):350-1. PubMed ID: 15365992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartylglucosaminuria: unusual neonatal presentation in Qatari twins with a novel aspartylglucosaminidase gene mutation and 3 new cases in a Turkish family.
    Opladen T; Ebinger F; Zschocke J; Sengupta D; Ben-Omran T; Shahbeck N; Moog U; Fischer C; Bürger F; Haas D; Ruef P; Harting I; Al-Rifai H; Hoffmann GF
    J Child Neurol; 2014 Jan; 29(1):36-42. PubMed ID: 23271757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of mutations in aspartylglucosaminuria.
    Ikonen E; Aula P; Grön K; Tollersrud O; Halila R; Manninen T; Syvänen AC; Peltonen L
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11222-6. PubMed ID: 1722323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular analysis of the aspartylglucosaminidase gene in Japanese patients with aspartylglucosaminuria].
    Yoshida K
    Nihon Rinsho; 1993 Sep; 51(9):2308-13. PubMed ID: 8411707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mutations in a Canadian family with aspartylglucosaminuria and early outcome post bone marrow transplantation.
    Laitinen A; Hietala M; Haworth JC; Schroeder ML; Seargeant LE; Greenberg CR; Aula P
    Clin Genet; 1997 Mar; 51(3):174-8. PubMed ID: 9137882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartylglucosaminuria (AGU): protein and gene structure of normal and mutated aspartylglucosaminidase.
    Halila R; Ikonen E; Tollersrud O; Syvänen AC; Enomaa N; Peltonen L
    Biochem Med Metab Biol; 1993 Aug; 50(1):1-8. PubMed ID: 8373629
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease.
    Ikonen E; Baumann M; Grön K; Syvänen AC; Enomaa N; Halila R; Aula P; Peltonen L
    EMBO J; 1991 Jan; 10(1):51-8. PubMed ID: 1703489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A family with two children diagnosed with aspartylglucosaminuria-case report and literature review].
    Liu Y; Zou L; Meng Y; Zhang Y; Shi X; Ju J; Yang G; Hu L; Chen X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):455-9. PubMed ID: 25190167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria.
    Banning A; Schiff M; Tikkanen R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):668-675. PubMed ID: 29247835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of exon 8 causes glycosylasparaginase deficiency in an African American aspartylglucosaminuria (AGU) patient.
    Fisher KJ; Aronson NN
    FEBS Lett; 1991 Aug; 288(1-2):173-8. PubMed ID: 1879549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a point mutation in aspartylglucosaminidase gene: evidence for a readthrough of a translational stop codon.
    Peltola M; Chiatayat D; Peltonen L; Jalanko A
    Hum Mol Genet; 1994 Dec; 3(12):2237-42. PubMed ID: 7881426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assignment of the aspartylglucosaminidase gene (AGA) to 4q33----q35 based on decreased activity in a girl with a 46,XX,del(4)(q33) karyotype.
    Engelen J; Hamers A; Schrander-Stumpel C; Mulder H; Poorthuis B
    Cytogenet Cell Genet; 1992; 60(3-4):208-9. PubMed ID: 1505217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangement.
    Jalanko A; Manninen T; Peltonen L
    Hum Mol Genet; 1995 Mar; 4(3):435-41. PubMed ID: 7795599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartylglucosaminuria caused by a novel homozygous mutation in the AGA gene was identified by an exome-first approach in a patient from Japan.
    Yamamoto T; Shimojima K; Matsufuji M; Mashima R; Sakai E; Okuyama T
    Brain Dev; 2017 May; 39(5):422-425. PubMed ID: 28063748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations.
    Saarela J; Laine M; Oinonen C; von Schantz C; Jalanko A; Rouvinen J; Peltonen L
    Hum Mol Genet; 2001 Apr; 10(9):983-95. PubMed ID: 11309371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartylglucosaminuria among Palestinian Arabs.
    Zlotogora J; Ben-Neriah Z; Abu-Libdeh BY; Sury V; Zeigler M
    J Inherit Metab Dis; 1997 Nov; 20(6):799-802. PubMed ID: 9427148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetics of aspartylglucosaminuria].
    Palotie L; Ikonen E; Syvänen AC; Halila R; Enomaa N; Heiskanen T; Grön K; Aula P
    Duodecim; 1991; 107(23-24):1916-25. PubMed ID: 1366100
    [No Abstract]   [Full Text] [Related]  

  • 20. A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13.
    Thomassen M; Kruse TA; Jensen PK; Gerdes AM
    Genet Test; 2006; 10(2):116-20. PubMed ID: 16792514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.